Results 111 to 120 of about 16,319 (214)
Cardioverting acute atrial fibrillation and the risk of thromboembolism: not all patients are created equal [PDF]
Current guidelines support the well-established clinical practice that patients who present with atrial fibrillation (AF) of less than 48 hours duration should be considered for cardioversion, even in the absence of pre-existing anticoagulation. However,
Rankin, Alastair J., Rankin, Stephen H.
core +1 more source
Transcatheter PFO closure for cryptogenic stroke: current approaches and future considerations
Patent Foramen Ovale (PFO) is a common congenital atrial septal defect present in 20%–35% of the general population. Although generally considered a benign anatomic variant, a PFO may facilitate passage of a thrombus from the venous to arterial ...
Moemen Eltelbany +5 more
doaj +1 more source
Embolic stroke of undetermined source: a retrospective analysis from an Italian Stroke Unit
The new clinical construct of embolic stroke of undetermined source (ESUS) suggests that many cryptogenic strokes are related to minor-risk covert embolic cardiac sources or to embolus from non-occlusive plaques in the aortic arch or in the cerebral ...
Marco Masina +5 more
doaj +1 more source
Risk factors for ischemic stroke and transient ischemic attack in patients under age 50 [PDF]
To analyze risk factors for ischemic stroke and transient ischemic attack (TIA) in young adults under the age of 50. To make recommendations for additional research and practical consequences. From 97 patients with ischemic stroke or TIA under the age of
A. W. M. Janssen +2 more
core +1 more source
Objective Recent anticoagulation trials in all-comer cryptogenic stroke patients have yielded equivocal results, reinvigorating the focus on identifying reproducible markers of an atrial myopathy.
Louise Roberts +11 more
doaj +1 more source
Smoking affects gene expression in blood of patients with ischemic stroke. [PDF]
ObjectiveThough cigarette smoking (CS) is a well-known risk factor for ischemic stroke (IS), there is no data on how CS affects the blood transcriptome in IS patients.MethodsWe recruited IS-current smokers (IS-SM), IS-never smokers (IS-NSM), control ...
Ander, Bradley P +6 more
core +2 more sources
Patent Foramen Ovale and Cryptogenic Stroke: Challenges in Diagnosis and Management
A patent foramen ovale (PFO) is a common disorder that affects between 20-34% of the adult population. This condition is a benign finding for most people.
Dhanang Ali Yafi, Azmi Azmi
doaj
Cryptogenic embolic stroke and cancer
Oncologic and cerebrovascular diseases are among the diseases with the highest incidence rate and are leading causes of disability and mortality. The relationship between cancer and cerebrovascular disease has been studied for decades, yet it remains a challenge.
Joaquin Carneado-Ruiz +1 more
openaire +3 more sources
Putting cryptogenic stroke into perspective
Key Points In patients who have a cryptogenic stroke and have their PFO closed, the recurrence rate of “cerebral ischemia” is much greater in patients who are older than 55 years. Most of these recurrent events (2 strokes and 4TIAs) in the older age group were due to identifiable causes.
openaire +4 more sources
Secondary stroke prevention: patent foramen ovale, aortic plaque, and carotid stenosis [PDF]
Stroke is the most debilitating cardiovascular event. It has a variety of causes that may be present simultaneously. In young or otherwise healthy people, the search for a patent foramen ovale (PFO) has become standard.
Diener, Hans C. +3 more
core

